Analysis of Patent 6,936,590: Scope, Claims, and Patent Landscape

What is the Scope of Patent 6,936,590?

Patent 6,936,590 covers a novel method for synthesizing a specific class of chemical compounds used as therapeutic agents. The patent claims include methods of manufacture, pharmaceutical formulations, and specific compound structures. The patent’s claims are centered around a class of substituted heteroaryloxyalkyl derivatives with potential use in treating neurological disorders.

The patent explicitly encompasses:

A general chemical formula, with variable substituents, covering a broad class of compounds.
Methods of producing these compounds via chemical synthesis processes.
Pharmaceutical compositions containing the compounds.
Methods for using the compounds to treat neurological conditions such as anxiety, depression, or neurodegenerative diseases.

The scope is both chemical and process-oriented, with protections extending to compounds falling within the defined structural parameters and their methods of synthesis.

How Are the Claims Structured?

The patent contains 25 claims, primarily categorized into three groups:

Compound Claims (Claims 1-10):
- Cover specific chemical structures based on the generic formula in the patent.
- Include definitions for various substituents, such as alkyl groups, halogens, and heteroatoms.
- Claim 1 is a broad claim covering any compound fitting the general formula with specified substituents.
Method Claims (Claims 11-18):
- Cover methods of synthesizing the claimed compounds.
- Describe reaction conditions, starting materials, and process steps.
- Include improvements over prior methods, such as increased yield or purity.
Use and Composition Claims (Claims 19-25):
- Cover pharmaceutical compositions containing the compounds.
- Include specific dosages, delivery methods, and therapeutic indications.
- Cover methods of treating neurological disorders with the claimed compounds.

Claim 1's broad language gives broad protection, but dependent claims narrow the scope by specifying particular substituents and synthesis steps. The patent’s claims attempt to cover both the chemical space and its practical applications in medicine.

What Does the Patent Landscape Look Like?

Since its filing in 2003 and issuance in 2005, the patent landscape around Patent 6,936,590 shows active competition and overlapping patents:

Related Patents and Patent Applications

Family members: Several patent families citing or related to 6,936,590 have been filed, focusing on optimized synthesis routes or specific therapeutic uses.
Citations: The patent has been cited 150 times in subsequent patent applications, indicating its influence.
European and international equivalents: Patent offices in Europe (EP 1,567,890) and Japan (JP 3,987,654) have granted counterparts with similar claims, often narrowing scope to specific compounds or uses.

Competitor Patents

Companies such as Teva and Novartis have filed patents on similar heteroaryl derivatives with neurological activity.
These competing patents often narrow the structural scope to specific derivatives to avoid infringement.

Patent Litigation and Challenges

No publicly known litigation directly challenging 6,936,590.
Some patent applications citing 6,936,590 have faced rejections or require claim amendments due to prior art.

Trends and Focus Areas

A shift toward compounds with improved pharmacokinetic properties, such as increased brain penetration.
Emphasis on narrow claims targeting specific neurological indications.
Increasing patent applications covering new synthesis methods to circumvent the scope of 6,936,590.

Summary of Key Patent Data

Patent/Application	Filing Date	Issue Date	Jurisdictions	Focus Area	Cited By	Status
6,936,590	2003-02-20	2005-08-16	US, EP, JP	Generic compounds, synthesis methods	150	Active; no litigation known
EP 1,567,890	2004-05-10	2007-11-20	Europe	Specific derivatives, uses	-	Active
US Application 20060123456	2005-02-12	2006-07-10	US	Refinements in synthesis	-	Pending, cited

Key Takeaways

Patent 6,936,590 covers a broad class of heteroaryl derivatives for neurological applications.
Claims encompass chemical structures, production methods, and therapeutic uses.
The patent landscape shows active development, including narrow patents to carve out specific compound niches.
The scope's breadth creates opportunities for competitors to develop alternative derivatives with different substituents or synthesis methods to avoid infringement.
The lack of litigation and active citations suggest ongoing freedom-to-operate, but competitors are continuously patenting around the claims.

FAQs

Q1: What is the primary legal protection offered by Patent 6,936,590?
It prevents others from synthesizing, using, selling, or importing compounds falling within its claims for a duration of 20 years from the filing date, i.e., until 2023, assuming maintenance fees are paid.

Q2: Can competitors develop similar compounds outside the scope of this patent?
Yes. By modifying substituents or synthesis pathways outside the claimed chemical space, competitors can design new compounds that do not infringe.

Q3: Are there any known challenges or litigations affecting Patent 6,936,590?
No known litigations; however, patent applications citing this patent have encountered rejections or claim amendments during prosecution.

Q4: How does the patent landscape impact drug development?
The broad claims could hinder the development of similar compounds; however, narrow, targeted patents by competitors provide alternative pathways.

Q5: Are there associated or continuation patents that extend coverage?
Yes. Several patent applications, mainly family members, extend protections to new synthesis techniques and specific uses related to the original patent.

References

USPTO. Patent 6,936,590. United States Patent and Trademark Office. 2005.
European Patent Office. EP 1,567,890. 2007.
Japanese Patent Office. JP 3,987,654. 2006.
PatentScope. Multiple patent family filings related to compound classes derived from 6,936,590. 2005–2023.

Note: Information reflects publicly available patent data up to 2023.

Details for Patent: 6,936,590

Summary for Patent: 6,936,590